Analyst Ratings for Ligand Pharma (LGND)
LGND Rating Summary
LGND Price Target Summary
- Highest: $330.00 (Craig-Hallum)
- Lowest: $220.00 (Benchmark)
- Average: $272.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$272.88 (-0.7%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 75%
Avg. $ Target:
$272.88 (-0.7%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2026 | Oppenheimer | Leland Gershell | New Coverage | Outperform (N/A) |
285.00 (N/A) |
227.44 (274.88) |
20.86% | Details |
| 3/11/2026 | BofA Securities » Updated 4/27/2026 |
Jason Zemansky | New Coverage | Buy (N/A) |
260.00 (250.00) |
212.29 (274.88) |
29.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
